There were no significant differences in terms of clinical cure OR 1.04:0.69-1.5695% IC not three months after the beginning of treatment, nor were there any differences regarding adverse events between azithromycin and penicillin benzathine OR 1.43:0.42-4.9595% CI.
No hubo diferencias significativas en términos de cura clínica OR = 1,04; IC 95%: 0,69-1,56, como tampoco a los tres meses. Tampoco hubo diferencias en términos de eventos adversos entre la azitromicina y la penicilina benzatínica OR 1,43; 95% CI 0,42-4,95.